Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to TRAM1
- Molecular classification
- Other, Long non-coding RNA, natural antisense transcript
01
Overview
This transcript is a non-coding RNA classified as a natural antisense transcript overlapping the TRAM1 locus. NATs are widely present in eukaryotes and are thought to regulate the expression of their corresponding sense genes via mechanisms such as transcriptional interference, RNA masking, RNA duplex formation, and epigenetic modification. While NATs can modulate gene expression, tissue specificity and physiological roles are often gene- and context-dependent, and for ENSG00000298363 ("novel transcript, antisense to TRAM1"), there is no functional characterization or evidence of direct therapeutic value. No protein, classical molecular function, or disease association has been verified for this locus[2][4][5].
- Other names
- ENSG00000298363
02
Biological functions
Regulation of gene expression (e.g., transcriptional interference, RNA masking, epigenetic regulation) inferred from NAT biology
03
Disease associations
OtherPotential regulatory role; no direct disease association reported
Beyond the preview
Go deeper on Novel transcript, antisense to TRAM1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel transcript, antisense to TRAM1.